Incision Management: Strategies in the Optimal Application and Management of Negative Pressure Wound Therapy

Jointly provided by Postgraduate Institute for Medicine and CMEology.

This activity is supported by an independent educational grant from Smith & Nephew.

Scroll to the Bottom of this Information to Begin this Course

Release date: April 29, 2016

Valid through: April 29, 2017

Media: Internet

Estimated Time to Complete Activity: 1.0 hour

Target Audience

This activity is designed for a multidisciplinary audience including physicians, registered nurses, pharmacists, and physical therapists. PIM will provide AMA PRA Category 1 Credit™ for physicians, ANCC credits for registered nurses and APRNs, and ACPE credits for pharmacists. The California Physical Therapy Association (CPTA) has approved this course for 1.0 contact hour/.01 CEUs.

Program Overview

Health Spectrum is a dynamic platform designed for healthcare professionals who want more from their educational experience. Enter a “virtual office”, where you will learn about Joseph, a 65-year-old man who underwent hip arthroplasty due to osteoarthritis and received Negative Pressure Wound Therapy to promote optimal wound healing. You will navigate your way through his interactive patient chart, view text/video, expert faculty commentary and animated graphs. Click on colored/hyperlinked words for extra “pop-up” information in each tab. Answer questions and see how your answers compare to those of your peers.

This is a composite case reflective of potential clinical management in multiple patients. It is designed for educational purposes only.

Learning Objectives

After completing this activity, participants will be better able to:

  • Describe principles of NPWT in incision management and the mechanism of action
  • Identify patients who are candidates for incision management with NPWT
  • Implement evidence based practices in NPWT application and management

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit
  • Nurses1.0 contact hour
  • Pharmacists1.0 contact hour
  • Physical Therapists1.0 contact hour

All other healthcare professionals completing this course will be issued a statement of participation.

Faculty

Robert Dionisio Galiano, MD, FACS
Associate Professor of Plastic Surgery
Feinberg School of Medicine at Northwestern University
Northwestern Memorial Hospital
Chicago, Illinois

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and CMEology. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Accreditation Statement

Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation

This educational activity for 1.0 contact hour is provided by Postgraduate Institute for Medicine.

Pharmacist Continuing Education

Accreditation Statement

Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s)
(0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number 0809-9999-16-085-H01-P.

Type of Activity

Application

Physical Therapy Continuing Education

Credit Designation

This course is approved for 1.0 contact hour/.01 CEUs by the California Physical Therapy Association (CPTA) #16-126.

Disclosures of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

Robert Dionisio Galiano, MD, FACS
  • Fees for Non-CME/CE Services: Smith & Nephew, Musculoskeletal Transplant Foundation, KCI-Acelity

The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following CMEology planners and managers, Sylvie Laflamme, Rob Lowney, and Dana Ravyn, PhD, MPH, hereby state that they or their spouse/ life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Method of Participation and Request for Credit

There are no fees for participating and receiving CME/CE credit for this activity. During the period April 29, 2016 through April 29, 2017, participants must read the learning objectives and faculty disclosures and study the educational activity.

For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Microsoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.